Meghan Brennan

Meghan Brennan is the Chief Operating Officer at TRIO-US, Inc., where she oversees a national site management organization focused on translational oncology clinical research. She previously held positions at City of Hope and UCLA Health, where she managed clinical research operations and execution of clinical trials for adult and pediatric oncology. Meghan holds a Ph.D. in Nursing from UCLA, a Master's Degree in Nurse Practitioner, and a BSN from Georgetown University.